Media and entertainment
Deal value surged 317% as volume declined 10%, concentrating growth in fewer, larger transactions. Activity centered on premium sports franchises, live entertainment venues and scaled media platforms with strong brands and engaged audiences. Buyers pursued geographic expansion, broader reach and integrated ecosystems to drive commercial growth and diversify revenue.
Life sciences
M&A strengthened, with deal value increasing 35% and volume rising 66%, indicating growth was driven by a larger number of smaller transactions. Activity focused on pipeline expansion, therapeutic diversification and integrated diagnostic and manufacturing capabilities. Buyers prioritized differentiated late-stage assets and novel treatment platforms across oncology, immunology and rare diseases.
Oil and gas, chemicals
M&A activity, slowed with deal value declining 40% and volume falling 27%, reflecting more selective capital deployment. Activity pointed to consolidation and vertical integration across midstream infrastructure, alongside investment in energy infrastructure supporting data centers and AI workloads. Buyers pursued greater processing and transportation capacity, integrated operating footprints and contracted cash flows to capture synergies and build scale.
Insurance
M&A surged, with deal value increasing 427% and volume rising 100%, indicating deal volume and volume rose sharply amplified by larger transactions. Activity centered on consolidation across insurance distribution, specialty risk and regional underwriting platforms, alongside technology-led modernization. Buyers pursued greater market reach, portfolio diversification and vertical integration while targeting AI-enabled advisory, underwriting and workflow capabilities to enhance operating efficiency.